CAS: 1004757-96-3
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
N-[5-[Methyl(propan-2-yl)amino]-2-[2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide REF: 3D-EQB75796CAS: 1004757-96-3 | Min. 95% | To inquire | Wed 22 Jan 25 | |
BMS-741672 REF: TM-T71640CAS: 1004757-96-3 | - - - | 2,890.00 €~5,288.00 € | Wed 12 Mar 25 |
N-[5-[Methyl(propan-2-yl)amino]-2-[2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide
CAS:1004757-96-3
N-[5-[Methyl(propan-2-yl)amino]-2-[2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide (NAPQI) is a new drug that is being developed for the treatment of autoimmune …
Formula:
C25H33F3N6O2
Purity:
Min. 95%
Molecular weight:
506.6 g/mol
Ref: 3D-EQB75796
100mg | To inquire | ||
250mg | To inquire |
Estimated delivery in United States, on Wednesday 22 Jan 2025
BMS-741672
CAS:1004757-96-3
BMS-741672 is a potent, selective CCR2 antagonist for the treatment of neuropathic pain.
Formula:
C25H33F3N6O2
Color and Shape:
Liquid
Molecular weight:
506.56
Ref: TM-T71640
25mg | 2,890.00 € | ||
50mg | 3,811.00 € | ||
100mg | 5,288.00 € |
Estimated delivery in United States, on Wednesday 12 Mar 2025